Multicenter segmentectomy in VR

Multicenter VR-guided Segmentectomy Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON27754

Enrollment

100

Registered

2021-09-04

Start date

2022-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung carcinoma (NSCLC), benign pathologie (bronchiectasis, hamartoma) or metastatic pulmonary lesion

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Indication for lung segment resection. Patient older than 18 years, operation planned in one of participating centers. Diagnostic CT thorax with max slide width of 1,5mm available. (High suspicion of ) lung carcinoma NSCLC stage 1A1/1A2 (cT1a/bN0M0) not centrally located and suitable for segment resection, or benign pathology (ie hamartoma) suitable for segment resection, or metastatic pulmonary lesion (extra thoracic origin or reoccuring lung carcinoma) suitable for segment resection

Exclusion criteria

Exclusion criteria: No informed consent for using VR as preoperative tool, patient wish for lobectomy instead of segmentectomy, not suitable for segmentectomy based on preoperative screening

Design outcomes

Primary

Measure	Time frame
Additional value of advanced imaging (based on 3D-VR and AI technology) over 2D-CT	—

Secondary

Measure	Time frame
Percentage change of plan due to 3D-VR planning, percentage more lung sparing, preoperative planning time of 3D-VR and 2D-CT, consensus between different participating centers. Similarities between parameters in 3D-VR and real-life, Ease-of-use of 3D-VR software, perioperative outcomes of VR-guided segmentectomies.	—

Contacts

Public ContactWouter Bakhuis

Erasmus MC

w.bakhuis@erasmusmc.nl0618661770

Outcome results